Cancer risks in <i>BRCA2</i> families: estimates for sites other than breast and ovaryChristi J. van Asperen|Journal of Medical Genetics|2005Cited by 421
Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological CharacteristicsMontserrat García‐Closas, Jenny Chang‐Claude, Børge G. Nordestgaard et al.|PLoS Genetics|2008Cited by 395
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth Page, Manuel R. Teixeira, Elizabeth Bancroft et al.|European Urology|2019Cited by 239
BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significanceDiana Eccles, David E. Goldgar, Gillian Mitchell et al.|Annals of Oncology|2015Cited by 220